Mawi DNA Technologies

Mawi DNA Technologies manufactures innovative biosample collection and stabilization devices for genomics, microbiome analysis, and molecular diagnostics. The company's flagship product line, iSWAB®, comprises proprietary swab-and-buffer systems designed to preserve DNA/RNA integrity while selectively controlling contamination. Key products include iSWAB-DNA (for human genomics with bacterial contamination suppression), iSWAB-RC-EL (FDA-cleared upper respiratory tract transport media suitable for extraction-less molecular testing), iSWAB-Microbiome (for microbiome sequencing and COVID-19 testing), iSWAB-Animal (for vertebrate DNA preservation in wildlife and zoological applications), and iSWAB-RNA. The company serves clinical laboratories, research institutions, forensic facilities, direct-to-consumer genomics companies, and animal science organizations. Products utilize non-toxic, proprietary lytic buffers that stabilize high molecular weight genomic DNA at variable temperatures and are suitable for infants through elderly populations. Mawi holds FDA clearance for select devices, CE marking for IVD use in EU markets, ISO 13485 certification, and UKCA approval. The company partners with genomics platforms, diagnostic test developers, and research institutions. Manufacturing and quality systems comply with medical device and research-grade standards.